245 related articles for article (PubMed ID: 30324231)
1. Increased serum Th2 chemokine levels are associated with bronchopulmonary dysplasia in premature infants.
Zhou D; Shi F; Xiong Y; Zhou M; Wan H; Liu H
Eur J Pediatr; 2019 Jan; 178(1):81-87. PubMed ID: 30324231
[TBL] [Abstract][Full Text] [Related]
2. Urinary leukotriene E(4) excretion during the first month of life and subsequent bronchopulmonary dysplasia in premature infants.
Sheikh S; Null D; Gentile D; Bimle C; Skoner D; McCoy K; Guthrie R
Chest; 2001 Jun; 119(6):1749-54. PubMed ID: 11399701
[TBL] [Abstract][Full Text] [Related]
3. Serum eotaxin-1 is increased in extremely-low-birth-weight infants with bronchopulmonary dysplasia or death.
Kandasamy J; Roane C; Szalai A; Ambalavanan N
Pediatr Res; 2015 Nov; 78(5):498-504. PubMed ID: 26270578
[TBL] [Abstract][Full Text] [Related]
4. NTproBNP is a useful early biomarker of bronchopulmonary dysplasia in very low birth weight infants.
Méndez-Abad P; Zafra-Rodríguez P; Lubián-López S; Benavente-Fernández I
Eur J Pediatr; 2019 May; 178(5):755-761. PubMed ID: 30820654
[TBL] [Abstract][Full Text] [Related]
5. B-type natriuretic peptide levels in preterm neonates with bronchopulmonary dysplasia: a marker of severity?
Kalra VK; Aggarwal S; Arora P; Natarajan G
Pediatr Pulmonol; 2014 Nov; 49(11):1106-11. PubMed ID: 24214578
[TBL] [Abstract][Full Text] [Related]
6. Role of NT-proBNP in the prediction of moderate to severe Bronchopulmonary Dysplasia in preterm infants.
Khan S; Concina VA; Schneider D; Westgate P; Arriagada S; Bada H
Pediatr Pulmonol; 2020 Feb; 55(2):376-382. PubMed ID: 31869001
[TBL] [Abstract][Full Text] [Related]
7. Incidence of metabolic bone disease in preterm infants of birth weight <1250 g and in those suffering from bronchopulmonary dysplasia.
Gaio P; Verlato G; Daverio M; Cavicchiolo ME; Nardo D; Pasinato A; de Terlizzi F; Baraldi E
Clin Nutr ESPEN; 2018 Feb; 23():234-239. PubMed ID: 29460805
[TBL] [Abstract][Full Text] [Related]
8. Angiogenic Factors in Cord Blood of Preterm Infants Predicts Subsequently Developing Bronchopulmonary Dysplasia.
Yang WC; Chen CY; Chou HC; Hsieh WS; Tsao PN
Pediatr Neonatol; 2015 Dec; 56(6):382-5. PubMed ID: 25997993
[TBL] [Abstract][Full Text] [Related]
9. Cord blood KL-6, a specific lung injury marker, correlates with the subsequent development and severity of atypical bronchopulmonary dysplasia.
Kim DH; Kim HS; Shim SY; Lee JA; Choi CW; Kim EK; Kim BI; Choi JH
Neonatology; 2008; 93(4):223-9. PubMed ID: 18025794
[TBL] [Abstract][Full Text] [Related]
10. Early clinical markers for the development of bronchopulmonary dysplasia: soluble E-Selectin and ICAM-1.
Ramsay PL; O'Brian Smith E; Hegemier S; Welty SE
Pediatrics; 1998 Oct; 102(4 Pt 1):927-32. PubMed ID: 9755267
[TBL] [Abstract][Full Text] [Related]
11. IFN-γ and IP-10 in tracheal aspirates from premature infants: relationship with bronchopulmonary dysplasia.
Aghai ZH; Saslow JG; Mody K; Eydelman R; Bhat V; Stahl G; Pyon K; Bhandari V
Pediatr Pulmonol; 2013 Jan; 48(1):8-13. PubMed ID: 22431160
[TBL] [Abstract][Full Text] [Related]
12. Correlates of Elevated Interleukin-6 and 8-Hydroxy-2'-Deoxyguanosine Levels in Tracheal Aspirates from Very Low Birth Weight Infants Who Develop Bronchopulmonary Dysplasia.
Hsiao CC; Chang JC; Tsao LY; Yang RC; Chen HN; Lee CH; Lin CY; Tsai YG
Pediatr Neonatol; 2017 Feb; 58(1):63-69. PubMed ID: 27321203
[TBL] [Abstract][Full Text] [Related]
13. Predictive values of plasma KL-6 in bronchopulmonary dysplasia in preterm infants.
Dilli D; Özyazici A; Dursun A; Beken S
Turk J Med Sci; 2017 Apr; 47(2):621-626. PubMed ID: 28425256
[TBL] [Abstract][Full Text] [Related]
14. Serum cytokine concentrations, chorioamnionitis and the onset of bronchopulmonary dysplasia in premature infants.
Kaneko M; Sato M; Ogasawara K; Imamura T; Hashimoto K; Momoi N; Hosoya M
J Neonatal Perinatal Med; 2017; 10(2):147-155. PubMed ID: 28409755
[TBL] [Abstract][Full Text] [Related]
15. Cord Blood Biomarkers of Placental Maternal Vascular Underperfusion Predict Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.
Mestan KK; Gotteiner N; Porta N; Grobman W; Su EJ; Ernst LM
J Pediatr; 2017 Jun; 185():33-41. PubMed ID: 28162769
[TBL] [Abstract][Full Text] [Related]
16. Role of antioxidant nutrients and lipid peroxidation in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia.
Falciglia HS; Johnson JR; Sullivan J; Hall CF; Miller JD; Riechmann GC; Falciglia GA
Am J Perinatol; 2003 Feb; 20(2):97-107. PubMed ID: 12660915
[TBL] [Abstract][Full Text] [Related]
17. Endothelin 1 as a predictor marker for bronchopulmonary dysplasia in preterm neonates with respiratory distress syndrome.
El Shemi MS; Tawfik S; Khafagy SM; Hamza MT; Youssef AM
J Neonatal Perinatal Med; 2017; 10(1):79-83. PubMed ID: 28304322
[TBL] [Abstract][Full Text] [Related]
18. Serial changes of serum endostatin and angiopoietin-1 levels in preterm infants with severe bronchopulmonary dysplasia and subsequent pulmonary artery hypertension.
Kim DH; Kim HS
Neonatology; 2014; 106(1):55-61. PubMed ID: 24818792
[TBL] [Abstract][Full Text] [Related]
19. Serum surfactant protein D as a marker for bronchopulmonary dysplasia.
Vinod S; Gow A; Weinberger B; Potak D; Hiatt M; Chandra S; Hegyi T
J Matern Fetal Neonatal Med; 2019 Mar; 32(5):815-819. PubMed ID: 29025303
[TBL] [Abstract][Full Text] [Related]
20. Increased ADMA levels are associated with poor pulmonary outcome in preterm neonates.
Kavurt S; Demirel N; Bas AY; Ulubas Isık D; Ozcan B; Aydemir O
J Matern Fetal Neonatal Med; 2017 Apr; 30(7):864-869. PubMed ID: 27268203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
